Edwards Lifesciences Financial Ratios
NYSE: EWHealth CareIndustrial SpecialtiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Edwards Lifesciences ratio analysis
Edwards Lifesciences earned a net margin of 17.7% in FY 2025, down from 76.7% a year earlier. Gross margin was 78.0% compared with a median of 75.4% over the prior 9 years. Return on equity reached 10.4%, meaning Edwards Lifesciences generated 0.10 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.06 versus 0.06 the year before, and the current ratio was 3.72. At the end of FY 2025, EW traded at 46.6 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 10.6 to 70.2, with a median of 38.5. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Edwards Lifesciences financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 46.63 | 10.60 | 33.15 | 30.58 | 54.43 | 70.18 | 47.08 | 43.87 | 13.91 | 11.97 |
| Price / sales | 8.22 | 8.12 | 9.23 | 10.35 | 15.43 | 12.95 | 11.09 | 8.36 | 2.31 | 2.24 |
| Price / book | 4.83 | 4.42 | 6.96 | 7.95 | 13.84 | 12.42 | 11.63 | 9.91 | 2.68 | 2.54 |
| Gross margin | 78.0% | 79.5% | 80.5% | 83.8% | 76.1% | 75.4% | 74.4% | 74.8% | 74.5% | 73.1% |
| Operating margin | 20.8% | 25.3% | 26.1% | 33.6% | 32.3% | 20.5% | 26.4% | 20.1% | 31.7% | 25.3% |
| Net margin | 17.7% | 76.7% | 28.0% | 34.1% | 28.7% | 18.8% | 24.1% | 19.4% | 17.0% | 19.2% |
| Free cash flow margin | 22.0% | 5.3% | 12.8% | 21.8% | 26.9% | 14.8% | 21.4% | 18.5% | 24.2% | 17.8% |
| Return on equity (ROE) | 10.4% | 41.8% | 21.1% | 26.2% | 25.8% | 18.0% | 25.2% | 23.0% | 19.7% | 21.7% |
| Return on assets (ROA) | 7.8% | 32.0% | 15.0% | 18.4% | 17.7% | 11.4% | 16.1% | 13.6% | 10.3% | 12.6% |
| Debt / equity | 0.06 | 0.06 | 0.09 | 0.10 | 0.10 | 0.13 | 0.14 | 0.19 | 0.35 | 0.31 |
| Current ratio | 3.72 | 4.18 | 3.38 | 3.03 | 3.08 | 3.46 | 3.31 | 2.61 | 1.80 | 4.21 |
| Revenue growth | 11.5% | 8.6% | 12.2% | -14.7% | 19.3% | 0.9% | 16.8% | 8.4% | 15.9% | 18.8% |
| EPS growth | -73.7% | 203.0% | -5.7% | 2.5% | 83.1% | -20.7% | 45.1% | -58.1% | 3.4% | 16.0% |